Symbol
AVIR on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
7,810,000 shares
Security Ownership %
9.9%

Leonard Braden Michael ownership in Atea Pharmaceuticals, Inc. Common Stock (AVIR)

09 Feb 2026 - Leonard Braden Michael has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,810,000 shares of Atea Pharmaceuticals, Inc. Common Stock (AVIR). This represents 9.9% ownership of the company. In their previous filing dated 16 Dec 2024, BML Investment Partners, L.P. had reported owning 7,216,312 shares, indicating an increase of +8.2%. .